Stimulating glutamatergic neurons as a potential novel therapeutic avenue for schizophrenia

Stimulating glutamatergic neurons as a potential novel therapeutic avenue for schizophrenia

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Folia Pharmacologica Japonica 2010, Vol.136(3), pp.128-132
Hauptverfasser: Nakato, Kazuhiro, Harada, Katsuya, Tobe, Takahiko, Yamaji, Takayuki, Takakura, Shoji
Format: Artikel
Sprache:jpn
Schlagworte:
Animals
Drug Design
Glutamates - analysis
Glycine - metabolism
Humans
Neurons - chemistry
Receptors, N-Methyl-D-Aspartate - antagonists & inhibitors
Sarcosine - therapeutic use
Schizophrenia - drug therapy
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 132
container_issue 3
container_start_page 128
container_title Folia Pharmacologica Japonica
container_volume 136
creator Nakato, Kazuhiro
Harada, Katsuya
Tobe, Takahiko
Yamaji, Takayuki
Takakura, Shoji
description
doi_str_mv 10.1254/fpj.136.128
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_755179923</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>755179923</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2568-5847ad40c4db3cfcb63a969b79e9d813617a15f24f5692b7362b89d956c3e3a3</originalsourceid><addsrcrecordid>eNo9kM1L7TAQxYMoerm6ci_duZD68tE0yVJEfQ-Et9CdizJNp_dG2rQmqaB_vZGrF4YZDvPjDHMIOWf0mnFZ_enn12sm6iz0AVkxUalSC6MOyYpSJktZG3ZCzmJ0LaVScVULdkxOONVCU8ZX5OUpuXEZIDm_KTbDkmCEhGHjbOFxCZOPBeQq5imhTw6Gwk_vOBRpiwFmXFIG4R39gkU_hSLarfuc5m1A7-CUHPUwRDz7mWvyfH_3fPu3fPz_8O_25rG0XNa6lLpS0FXUVl0rbG_bWoCpTasMmk7n55gCJnte9fkb3ipR81abzsjaChQg1uRyZzuH6W3BmJrRRYvDAB6nJTZKSqaM4SKTVzvShinGgH0zBzdC-GgYbb7jbHKcTb6Yhc70xY_v0o7Y7dnf8DJwswNeY4IN7gEIOZUB92bit3O939kthAa9-ALYIIkL</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>755179923</pqid></control><display><type>article</type><title>Stimulating glutamatergic neurons as a potential novel therapeutic avenue for schizophrenia</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Nakato, Kazuhiro ; Harada, Katsuya ; Tobe, Takahiko ; Yamaji, Takayuki ; Takakura, Shoji</creator><creatorcontrib>Nakato, Kazuhiro ; Harada, Katsuya ; Tobe, Takahiko ; Yamaji, Takayuki ; Takakura, Shoji</creatorcontrib><identifier>ISSN: 0015-5691</identifier><identifier>EISSN: 1347-8397</identifier><identifier>DOI: 10.1254/fpj.136.128</identifier><identifier>PMID: 20838012</identifier><language>jpn</language><publisher>Japan: The Japanese Pharmacological Society</publisher><subject>Animals ; Drug Design ; Glutamates - analysis ; Glycine - metabolism ; Humans ; Neurons - chemistry ; Receptors, N-Methyl-D-Aspartate - antagonists &amp; inhibitors ; Sarcosine - therapeutic use ; Schizophrenia - drug therapy</subject><ispartof>Folia Pharmacologica Japonica, 2010, Vol.136(3), pp.128-132</ispartof><rights>2010 by The Japanese Pharmacological Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2568-5847ad40c4db3cfcb63a969b79e9d813617a15f24f5692b7362b89d956c3e3a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,4025,27927,27928,27929</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20838012$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nakato, Kazuhiro</creatorcontrib><creatorcontrib>Harada, Katsuya</creatorcontrib><creatorcontrib>Tobe, Takahiko</creatorcontrib><creatorcontrib>Yamaji, Takayuki</creatorcontrib><creatorcontrib>Takakura, Shoji</creatorcontrib><title>Stimulating glutamatergic neurons as a potential novel therapeutic avenue for schizophrenia</title><title>Folia Pharmacologica Japonica</title><addtitle>Nihon Yakurigaku Zasshi</addtitle><subject>Animals</subject><subject>Drug Design</subject><subject>Glutamates - analysis</subject><subject>Glycine - metabolism</subject><subject>Humans</subject><subject>Neurons - chemistry</subject><subject>Receptors, N-Methyl-D-Aspartate - antagonists &amp; inhibitors</subject><subject>Sarcosine - therapeutic use</subject><subject>Schizophrenia - drug therapy</subject><issn>0015-5691</issn><issn>1347-8397</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kM1L7TAQxYMoerm6ci_duZD68tE0yVJEfQ-Et9CdizJNp_dG2rQmqaB_vZGrF4YZDvPjDHMIOWf0mnFZ_enn12sm6iz0AVkxUalSC6MOyYpSJktZG3ZCzmJ0LaVScVULdkxOONVCU8ZX5OUpuXEZIDm_KTbDkmCEhGHjbOFxCZOPBeQq5imhTw6Gwk_vOBRpiwFmXFIG4R39gkU_hSLarfuc5m1A7-CUHPUwRDz7mWvyfH_3fPu3fPz_8O_25rG0XNa6lLpS0FXUVl0rbG_bWoCpTasMmk7n55gCJnte9fkb3ipR81abzsjaChQg1uRyZzuH6W3BmJrRRYvDAB6nJTZKSqaM4SKTVzvShinGgH0zBzdC-GgYbb7jbHKcTb6Yhc70xY_v0o7Y7dnf8DJwswNeY4IN7gEIOZUB92bit3O939kthAa9-ALYIIkL</recordid><startdate>2010</startdate><enddate>2010</enddate><creator>Nakato, Kazuhiro</creator><creator>Harada, Katsuya</creator><creator>Tobe, Takahiko</creator><creator>Yamaji, Takayuki</creator><creator>Takakura, Shoji</creator><general>The Japanese Pharmacological Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2010</creationdate><title>Stimulating glutamatergic neurons as a potential novel therapeutic avenue for schizophrenia</title><author>Nakato, Kazuhiro ; Harada, Katsuya ; Tobe, Takahiko ; Yamaji, Takayuki ; Takakura, Shoji</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2568-5847ad40c4db3cfcb63a969b79e9d813617a15f24f5692b7362b89d956c3e3a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>jpn</language><creationdate>2010</creationdate><topic>Animals</topic><topic>Drug Design</topic><topic>Glutamates - analysis</topic><topic>Glycine - metabolism</topic><topic>Humans</topic><topic>Neurons - chemistry</topic><topic>Receptors, N-Methyl-D-Aspartate - antagonists &amp; inhibitors</topic><topic>Sarcosine - therapeutic use</topic><topic>Schizophrenia - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nakato, Kazuhiro</creatorcontrib><creatorcontrib>Harada, Katsuya</creatorcontrib><creatorcontrib>Tobe, Takahiko</creatorcontrib><creatorcontrib>Yamaji, Takayuki</creatorcontrib><creatorcontrib>Takakura, Shoji</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Folia Pharmacologica Japonica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nakato, Kazuhiro</au><au>Harada, Katsuya</au><au>Tobe, Takahiko</au><au>Yamaji, Takayuki</au><au>Takakura, Shoji</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Stimulating glutamatergic neurons as a potential novel therapeutic avenue for schizophrenia</atitle><jtitle>Folia Pharmacologica Japonica</jtitle><addtitle>Nihon Yakurigaku Zasshi</addtitle><date>2010</date><risdate>2010</risdate><volume>136</volume><issue>3</issue><spage>128</spage><epage>132</epage><pages>128-132</pages><issn>0015-5691</issn><eissn>1347-8397</eissn><cop>Japan</cop><pub>The Japanese Pharmacological Society</pub><pmid>20838012</pmid><doi>10.1254/fpj.136.128</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0015-5691
ispartof Folia Pharmacologica Japonica, 2010, Vol.136(3), pp.128-132
issn 0015-5691
1347-8397
language jpn
recordid cdi_proquest_miscellaneous_755179923
source MEDLINE; EZB-FREE-00999 freely available EZB journals
subjects Animals
Drug Design
Glutamates - analysis
Glycine - metabolism
Humans
Neurons - chemistry
Receptors, N-Methyl-D-Aspartate - antagonists & inhibitors
Sarcosine - therapeutic use
Schizophrenia - drug therapy
title Stimulating glutamatergic neurons as a potential novel therapeutic avenue for schizophrenia
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T10%3A42%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Stimulating%20glutamatergic%20neurons%20as%20a%20potential%20novel%20therapeutic%20avenue%20for%20schizophrenia&rft.jtitle=Folia%20Pharmacologica%20Japonica&rft.au=Nakato,%20Kazuhiro&rft.date=2010&rft.volume=136&rft.issue=3&rft.spage=128&rft.epage=132&rft.pages=128-132&rft.issn=0015-5691&rft.eissn=1347-8397&rft_id=info:doi/10.1254/fpj.136.128&rft_dat=%3Cproquest_cross%3E755179923%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=755179923&rft_id=info:pmid/20838012&rfr_iscdi=true